Aussie cannabis firms go capital-light as they roll into Europe Tread light and invest light we get that but there’s also the element of standard Australian approach of trying to get something for nothing. A handful of small, young Australian firms are taking a chance on Europe in spite of the region’s diverse markets, hopeful that a capital-light investment strategy will diminish their risks. Europe could be a hard market to crack as regulations vary by country, but favorable rulings for medical marijuana and potential demand are promising factors. The companies reckon that establishing an early base there and working with European partners will help them better negotiate different markets and steal a march on larger North American rivals. Cann Group and MGC Pharmaceuticals are among many firms that have pushed into Europe, recently signing partnerships to distribute medical marijuana products and also exploring a dual-listing in the region.

Cannabis Law Report, 02/24/2021 22:42:00

Open article: